Medical Discovery Partners LLC is a leading provider of quantitative IHC analytic standards, offering essential tools for making informed patient care decisions. Their innovative products replace outdated technologies, such as film cameras and VCR tapes, with digital solutions that provide instant image preview, storage, and sharing. With a focus on precision medicine, Medical Discovery Partners LLC is revolutionizing the field of immunohistochemistry by delivering calibrated IHC technology and liquid suspension IHC controls for improved performance and standardization.
Founded by industry experts Gail Radcliffe, PhD, and Joe Gentile, Medical Discovery Partners LLC combines scientific expertise with strategic consulting to assist medical device and diagnostics companies in areas such as regulatory strategy, market research, and clinical trial support. Their commitment to innovation and quality is evident in their patented products, including IHCalibrators and IHControls, which offer unparalleled homogeneity, reproducibility, and cost-effectiveness. With a strong emphasis on advancing precision medicine, Medical Discovery Partners LLC is at the forefront of standardizing IHC biomarker tests and enabling best practices in immunohistochemistry.
Generated from the website